Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services. Our aim is simple: to concentrate on markets where we can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. We are already the leading non-government genetic testing business in Australia, and through our wholly owned subsidiary Phenogen Sciences, we now have a solid and growing presence in the USA. We remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.

Pharmacia & Upjohn Co. LLC, a subsidiary of Pfizer Inc., is a company headquartered in Bingham Farms, MI, that manufactures and supplies pharmaceutical goods.

New Target (Shanghai) Molecular Medical Technology Co., Ltd., established on 2005-09-27, Business scope includes molecular medical technology,Technology development in the field of data analysis software,technical consulting,technology transfer,Technical Services,Engaged in the import and export of goods and technology. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

NitroMed is an emerging pharmaceutical company that discovers, develops and seeks to commercialize proprietary pharmaceuticals based on the therapeutic benefits of the naturally-occurring molecule nitric oxide. NitroMed is conducting a late-stage confirmatory trial of our lead nitric oxide-enhancing drug, BiDil, for the treatment of heart failure in African Americans.

G&G Science provides research and development services about DNA. It offers various studies and findings about advanced discoveries on the medical field. G&G Science was founded in 1999 and is headquartered in Fukishima.

Clinomics, Inc. conducts bio and medical research activities. It products and services include Clinomics TrioDx RT-PCR, COVID-19 Test (FDA EUA), liquid biopsy, precision medicine, health care, and big data. The company was founded on June 21, 2011 and is headquartered in Ulsan, South Korea.

Asia Genomics Pte Ltd. engages in medical industry. It focuses on implementing genomic technologies to connect researchers, healthcare professionals, companies and consumers with affordable genetic tests. The company was founded by Wong Mun Yew and is headquartered in Singapore.

Pathway Genomics provides a comprehensive set of genomic testing services across the healthcare spectrum, including tests for general health and wellness, liquid biopsy, pharmacogenomics, hereditary cancer risk and carrier screening. Its general health and wellness tests, including PathwayFit®, Cardiac DNA Insight®, and SkinFit™, equip physicians and patients with genetic information to support lifestyle choices. Liquid biopsy tests, including CancerIntercept™ Detect and Monitor, are non-invasive tests for detection of circulating tumor DNA. Pathway’s pharmacogenomics tests (Mental Health DNA Insight® and Pain Medication DNA Insight®) provide genetic information to help guide selection of optimal medication for management of mental health and pain disorders. Pathway’s hereditary cancer risk tests, including BRCATrue® and ColoTrue®, evaluate genetic factors for future cancer risk. Pathway Genomics Corporation operates a clinical laboratory to provide its commercial genetic testing services to physicians and their patients in the United States and internationally. Pathway Genomics Corporation was incorporated in 2008 and is based in San Diego, California.

Progenika Biopharma SA engages in the design and development of molecular biology testing solutions. The firm offers ID Core Control, ID RHD, ID Core, SeqPro Lipo IS, and A1AT genotyping test. The company was founded in 2000 and is headquartered in Derio, Spain.

Founded in beautiful Guangzhou in 2014, Top is a wholly-owned subsidiary of Top Medical Group. Top's gene has always been committed to patient-centered and improving human health. With the " gene + referral " integrated service, the combination of " scientific research + clinical " application, and the " gene + cell " dual-engine drive model, the clinical application of precision medicine is promoted, thus driving the rapid development of science and technology in the field of genes and cells.

TCI GENE, Inc. engages in provision of health management services. Its products include genetic testing, nutritious supplements, skincare, and antiaging. The company was founded on July 13, 2011 and is headquartered in Taipei, Taiwan.

Fu Wai Hospital, founded in 1956.

Geneus Health provides this powerful science and technology to improve addiction and behavior management for people everywhere. The Geneus Health clinically trialed and patented GARS Test, is the first test to accurately predict vulnerability to addictive, impulsive, and compulsive behaviors.

Shaanxi Jiuzhou Medical Laboratory Co., Ltd., established on 2015-04-17, Business scope includes licensed business items:Medical Testing Services.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)General operating items:Technology Development of Medical Testing,technical consulting,Technical service and technology promotion.(The above business scope excludes the special control and pre-licensing projects stipulated by the state)

Solexa engages in developing and commercializing genetic analysis technologies primarily in the United States and the United Kingdom. The company is developing and preparing Solexa Genome Analysis System, which performs DNA sequencing based on its proprietary reversible terminator Sequencing-by-Synthesis, chemistry, and Clonal Single Molecule Array technology. Its platform is designed to support a range of analyses, including whole genome resequencing, gene expression analysis, and small RNA analysis.

Shanghai Hengjian Biotechnology Co., Ltd., established on 2006-02-20, Business scope includes biological,Technical services in the field of medical technology,technical consulting,technology development,technology transfer,Biological Gene Testing Equipment,instrument,Biological Reagent Sales,software development,data processing,food circulation. [Items subject to approval by law,Business activities can only be carried out after approval by relevant departments]

SIFI is a leading player in the Italian ophthalmic industry. The company develops, manufactures and sells pharmaceutical treatments, diagnostic instruments and surgical equipment for eyecare, covering the vast majority of ocular pathologies.